Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1803 of 6351
-
Radioactive cocktail targets Hard-to-Treat breast cancer
Disease control OngoingThe purpose of this trial is to estimate the recommended dose (RD) of \[177Lu\]Lu-NeoB in combination with ribociclib and fulvestrant in participants with estrogen receptor (ER) positive (ER+), human epidermal growth factor receptor-2 (HER2) negative (HER2-) and gastrin releasing…
Phase 1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Immunotherapy-Chemo cocktail targets tough colon cancer before surgery
Disease control OngoingThis study aims to elucidate the effects of neoadjuvant Tislelizumab combined with chemotherapy in locally advanced Microsatellite Stable (MSS) colon cancer.
Phase 2 • Sponsor: First Affiliated Hospital of Guangxi Medical University • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New diabetes drug HTD1801 put to the test in 551-Person trial
Disease control CompletedThe goal of this clinical study is to evaluate the efficacy and safety of berberine ursodeoxycholate (HTD1801) compared to placebo in patients with type 2 diabetes inadequately controlled with metformin.
Phase 3 • Sponsor: Shenzhen HighTide Biopharmaceutical Ltd. • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Head elevation after stroke: simple move, big impact?
Disease control CompletedThe aim of this trial is to investigate whether head elevation position after endovascular treatment can improve the 90-day functional outcome of acute large vessel occlusion in the anterior circulation.
Sponsor: Zhengzhou Yuan • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New study aims to boost cervical cancer care for women with HIV
Knowledge-focused Recruiting nowWhile there has been a significant increase in the uptake of antiretroviral therapy among women living with HIV (WLHIV) in many low- and-middle income countries (LMICs), the coverage of cervical cancer screening and treatment (CCST) among WLHIV remains low. This study aims to lev…
Sponsor: University of California, San Diego • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC
-
New heart-zapping technique tested to improve irregular heartbeat treatment
Disease control OngoingPulmonary vein isolation (PVI) is very effective for rhythm control in patients with paroxysmal atrial fibrillation (AF), but less successful in patients with persistent AF. Adding posterior wall ablation (PWA) to PVI is among the most promising ablation strategies to improve arr…
Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Extended immunotherapy shows promise for tough prostate cancer
Disease control OngoingProposed immunotherapy with an extended course of Sipuleucel-T treatment may induce a more robust immune response and improve the anti-cancer efficacy of Sipuleucel-T in patients with metastatic Castration-Resistant Prostate Cancer (mCRPC).
Phase 1 • Sponsor: University of Oklahoma • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Green tea shows promise in preventing diabetes in obese kids
Disease control CompletedThe aim of this research is to evaluate the safety and efficacy of green tea in obese pediatrics with prediabetes versus the metformin therapy alone that is given to these patients. The primary outcome is to tackle the insulin resistance in these patients to prevent the deteriora…
Phase 3 • Sponsor: Ain Shams University • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Diabetes drug shows promise for PCOS in new study
Disease control CompletedChronic inflammation is the core of Polycystic ovary syndrome (PCOS), and obesity and overweight further exacerbate the level of inflammation in the peripheral circulation and ovarian tissue in PCOS patients. Metformin is a classic endocrine drug for the treatment of PCOS, but it…
Sponsor: Shanghai 10th People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New depression drug tested for long-term safety in 1,000 patients
Disease control OngoingThis is a 52-week open-label extension (OLE) study that will evaluate the safety, tolerability, and effectiveness of NMRA-335140 in participants with major depressive disorder (MDD). Participants who completed a parent study investigating the efficacy and safety of NMRA-335140 as…
Phase 3 • Sponsor: Neumora Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Stitch in time: new trial aims to stop preterm birth in High-Risk pregnancies
Disease control Recruiting nowThe goal of this clinical trial is to determine whether cervical cerclage reduces the risk of preterm birth in patients with a short transvaginal ultrasound (TVU) cervical length (CL) ≤25mm between 24 0/7-26 6/7 weeks.
Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Could a jolt of electricity make immunotherapy work better for melanoma?
Knowledge-focused By invitation onlyIn the last 10 years, the treatment of metastatic cutaneous melanoma has changed dramatically. The new systemic treatment with immunotherapy has led to a dramatic improvement in quality of life and overall survival. Systemic treatment means that the patient receives the drug as a…
Sponsor: Institute of Oncology Ljubljana • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC
-
New drug combo aims to control rare ovarian cancer
Disease control Recruiting nowTo learn if the combination of dostarlimab and LB-100 can help to control ovarian clear cell carcinoma
Phase 1/2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New hope for sarcoidosis patients: drug aims to tame lung inflammation and cut steroids
Disease control Recruiting nowA phase 1b/2 study of XTMAB-16 in patients with pulmonary sarcoidosis
Phase 1/2 • Sponsor: Xentria, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Can mixing lens types sharpen vision after cataract surgery?
Disease control CompletedThe goal of this clinical trial is to compare visual quality after cataract surgery between two groups: bilateral monofocal intraocular lenses (IOL) and monofocal and contralateral extended depth-of-focus (EDOF) IOL implantation. The main question it aims to answer is: • does th…
Sponsor: Vrije Universiteit Brussel • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Can a new polio vaccine stop the virus at the throat?
Knowledge-focused CompletedThe study will compare the poliovirus type-2 pharyngeal mucosal excretion in the first week, and at 2 and 4 weeks following the administration of a challenge novel OPV2 (nOPV2) dose at 18 weeks of age in 2 parallel groups of infants
Phase 4 • Sponsor: Fidec Corporation • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
New antibody drug shows promise for tough eczema cases
Disease control OngoingThis is a Phase IB/IIA clinical study of BAT6026 in patients with AD. The subjects were adults with moderate to severe atopic dermatitis (AD) whose disease was not adequately controlled by prior topical medications or for which topical medications were not appropriate. The first …
Phase 1/2 • Sponsor: Bio-Thera Solutions • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Old drug, new hope: atovaquone tested against tough ovarian cancer
Disease control Recruiting nowThis phase II trial test tests how well repurposing atovaquone works in treating patients with platinum-resistant ovarian cancer. Atovaquone is used for the treatment or prevention of certain infections. Atovaquone is in a class of medications called antiprotozoal agents. It work…
Phase 2 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 26, 2026 16:38 UTC
-
Can five radiation doses match longer treatment for breast cancer?
Knowledge-focused CompletedThe radiotherapy scheme with extreme hypofractionation has gained space in clinical practice and, therefore, it is necessary to analyze the Brazilian national experience in selected patients with breast cancer, with the aim of evaluating the oncological outcomes and toxicities wi…
Sponsor: Latin American Cooperative Oncology Group • Aim: Knowledge-focused
Last updated Aug 29, 2026 00:00 UTC
-
New Antibody-Drug conjugate STRO-002 tested in advanced cancers
Disease control CompletedThis is a multi-center, open-label, monotherapy dose escalation, PK bridging, and dose expansion Phase I/IIa study in Chinese adult subjects to evaluate the safety, tolerability, Pharmacokinetics (PK) profiles, immunogenicity, and preliminary efficacy of STRO-002 in patients with…
Phase 1/2 • Sponsor: Tasly Pharmaceutical Group Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC